Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil

@article{Peretti2004CognitiveSL,
  title={Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil},
  author={Charles Siegfried Peretti and Fabien Gierski and Sophie Harrois},
  journal={Psychopharmacology},
  year={2004},
  volume={176},
  pages={176-182}
}
RationaleCognitive skill learning, as assessed by repeated testing on the Tower of Toronto (TT) task, has been found to be impaired in normal aging. There is evidence that this impairment might be accounted for by the well-documented, age-dependent decline of dopamine D2-like receptor availability.ObjectivesThis study was an investigation of whether the D2/D3 dopaminergic agonist piribedil improves cognitive skill learning in older adults.MethodsHealthy elderly volunteers were assessed using… 
Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency
Memory Encoding and Dopamine in the Aging Brain: A Psychopharmacological Neuroimaging Study
TLDR
This study identifies a link between dopamine, episodic memory networks, and aging, using pharmacological functional magnetic resonance imaging and observes group differences, during memory encoding, in medial temporal, frontal, and striatal regions.
Impaired cognition and attention in adults: pharmacological management strategies
TLDR
“Drug therapeutic strategies” for improving cognition (except for memory function) are currently rather scarce, but promising perspectives for a new neurobiological approach to cognitive pharmacology will be highlighted.
[Mild cognitive impairment: modern aspects of diagnostics and therapy].
TLDR
The article provides a review of current literature on the diagnosis and treatment of mild cognitive impairment (MCI), with an emphasis on the use of the dopamine receptor agonist piribedil in the treatment of MCI and sensory deficit in elderly patients.
Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents
TLDR
The restoration of specific mnemonic impairments, in aged mice, highlights the memory-enhancing properties of piribedil and the efficacy of this drug in treating cognitive impairment of Parkinson's disease should now be assessed in more specific models.
Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD): An 11-Week Randomized Comparison Trial Against Pramipexole and Ropinirole
TLDR
This study shows that switching from pramipexole or ropinirole to piribedil has no effect on the reaction time of the TAP subtest vigilance but upholds the same therapeutic motor effect and reduces daytime sleepiness to a clinically relevant degree in patients with excessive daytimeSleepiness.
Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease
TLDR
Piribedil was considered in the last Movement Disorder Society Evidence-Based Medicine review as “efficacious” and “clinically useful” for the symptomatic treatment of PD, either as monotherapy or in conjunction with levodopa, in non-fluctuating early PD patients.
Motor control and aging: Links to age-related brain structural, functional, and biochemical effects
Neuropsychological Testing in the Diagnosis of Dementia
  • M. Sano
  • Psychology, Biology
    Journal of geriatric psychiatry and neurology
  • 2006
TLDR
Improved neuropsychological assessment and characterization of other domains, such as executive function and attention, may assist in better identifying the pathophysiology of deficits in these areas, perhaps in combination with new technologies such as functional imaging.
Visuomotor binding in older adults
...
1
2
3
...

References

SHOWING 1-10 OF 42 REFERENCES
Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers
TLDR
The performance pattern and verbal reports suggested that haloperidol impaired the higher cognitive functions such as the ability to shift from one strategy to another and/or to assess one’s performance accurately, possibly leading to the development of compensatory strategies.
Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment.
TLDR
The results support the role of age-related dopamine decline in cognitive impairment of the elderly and patients with mild cognitive impairment had improvement in global cognitive function when treated with the dopamine receptor agonist piribedil.
Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers
TLDR
Preliminary results suggest that chlorpromazine and lorazepam induced a double dissociation between priming and the acquisition of a cognitive routine, providing evidence that the two forms of implicit memory rely upon distinct neurochemical systems, the latter, but not the former, being dependent upon dopaminergic systems.
Age-related cognitive deficits mediated by changes in the striatal dopamine system.
TLDR
D(2) receptor binding is a more important factor than chronological age in accounting for variation in cognitive performance across the adult lifespan, and changes in dopamine neurotransmission play an important role in aging-related cognitive decline.
Cognitive skill learning and aging: a component process analysis.
TLDR
Investigating the ability to acquire a cognitive and motor skill using repeated testing on the Tower of Toronto puzzle found factors interfering with the generation of reliable goal structures are likely to prevent cognitive skill learning.
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.
TLDR
Age-related decreases in brain dopamine activity are associated with a decline in motor function and may also contribute to impaired performance on tasks that involve frontal brain regions, including measures of abstraction and mental flexibility.
Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers
TLDR
It is concluded that a single intravenous perfusion of piribedil 3 mg improves alertness and the information processing speed within the central nervous system, in healthy volunteers.
Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys
TLDR
The pattern of results is consistent with the greater loss of DA from the PFC than from motor areas in aged monkey brain, and indicates that DA depletion contributes significantly to age- related cognitive decline.
Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys
TLDR
Results underscore the importance of DA D1 mechanisms in cognitive function, and provide functional evidence of DA system degeneration in aged monkeys, suggesting that excessive D1 stimulation may be deleterious to cognitive function.
...
1
2
3
4
5
...